**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Birth: March 12, 1980
* Admission Date: March 10, 2023
* Discharge Date: March 20, 2023
* Diagnosis: Type 2 Diabetes Mellitus

**Hospital Course:**

John Doe, a 43-year-old male, was admitted to the endocrinology unit on March 10, 2023, with complaints of increasing thirst and urination over the past two months. His primary care physician referred him for further evaluation and management of his newly diagnosed type 2 diabetes.

Upon admission, John's vital signs were stable, and he was afebrile. His physical examination revealed no significant abnormalities. Laboratory tests revealed the following:

* Fasting Plasma Glucose (FPG): 220 mg/dL (> 11.1 mmol/L)
* Glycosylated Hemoglobin (HbA1C): 8.5% (indicating diabetes)
* Oral Glucose Tolerance Test (OGTT): Not performed due to patient's stable condition

**Diagnosis and Management:**

Based on the patient's laboratory results, John was diagnosed with type 2 diabetes mellitus. He was started on metformin 500 mg twice daily, with a plan to gradually increase the dose to 1000 mg twice daily over the next two weeks. He was also educated on the importance of diet, exercise, and patient self-monitoring of blood glucose levels.

In addition to metformin, John was prescribed semaglutide 2.4 mg subcutaneously once weekly for weight loss and improved glycemic control. He was also advised to adjust his insulin doses based on blood glucose levels and carbohydrate intake.

**Dietary Recommendations:**

John was educated on the importance of a balanced diet, focusing on whole foods and high-quality carbohydrates. He was advised to avoid sugary drinks and foods high in added sugars, saturated fats, and sodium. His dietary recommendations were individualized to accommodate his comorbid conditions, including hypertension and hyperlipidemia.

**Physical Activity:**

John was encouraged to engage in at least 150 minutes of moderate-intensity aerobic exercise per week, with adjustments for hypoglycemia risk. He was also advised to incorporate resistance exercises to improve his overall physical fitness and glycemic control.

**Patient Education:**

John received extensive education on the causes of diabetes, symptoms and signs of hypoglycemia, hyperglycemia, and diabetic complications. He was also educated on the importance of regular professional podiatric care, vaccinations, and medical devices and surgical treatments for obesity.

**Discharge Instructions:**

John was discharged from the hospital on March 20, 2023, with the following instructions:

* Continue metformin 1000 mg twice daily and semaglutide 2.4 mg subcutaneously once weekly
* Monitor blood glucose levels at home and adjust insulin doses based on levels and carbohydrate intake
* Engage in at least 150 minutes of moderate-intensity aerobic exercise per week and incorporate resistance exercises
* Follow a balanced diet focusing on whole foods and high-quality carbohydrates
* Attend regular follow-up appointments with his primary care physician and endocrinologist

**Next Steps:**

John will follow up with his primary care physician and endocrinologist in two weeks to review his progress and adjust his treatment plan as needed. He will also attend a diabetes education class to further improve his understanding of his condition and self-management skills.

**Follow-up Care:**

Regular follow-up care will be crucial to monitor John's progress, adjust his treatment plan, and prevent complications related to his type 2 diabetes mellitus. He will be monitored for signs and symptoms of hypoglycemia, hyperglycemia, and diabetic complications, and will receive regular vaccinations and podiatric care as recommended.

**Conclusion:**

John Doe, a 43-year-old male, was diagnosed with type 2 diabetes mellitus and received comprehensive management and education during his hospital stay. He was started on metformin and semaglutide, and received dietary recommendations and physical activity guidance. He was also educated on patient self-monitoring of blood glucose levels, adjusting insulin doses based on levels and carbohydrate intake, and regular follow-up care.